248 related articles for article (PubMed ID: 31765736)
1. Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells.
Yuan P; Yang T; Mu J; Zhao J; Yang Y; Yan Z; Hou Y; Chen C; Xing J; Zhang H; Li J
Cancer Lett; 2020 Jan; 469():498-509. PubMed ID: 31765736
[TBL] [Abstract][Full Text] [Related]
2. NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A.
Yuan P; Li J; Zhou F; Huang Q; Zhang J; Guo X; Lyu Z; Zhang H; Xing J
Cell Death Dis; 2017 Mar; 8(3):e2704. PubMed ID: 28333141
[TBL] [Abstract][Full Text] [Related]
3. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
[TBL] [Abstract][Full Text] [Related]
4. NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling.
Ma S; Chen Y; Quan P; Zhang J; Han S; Wang G; Qi R; Zhang X; Wang F; Yuan J; Yang X; Jia W; Qin W
BMC Cancer; 2023 Mar; 23(1):280. PubMed ID: 36978001
[TBL] [Abstract][Full Text] [Related]
5. Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells.
Yao G; Yin J; Wang Q; Dong R; Lu J
Biomed Res Int; 2019; 2019():2560650. PubMed ID: 31781603
[TBL] [Abstract][Full Text] [Related]
6. TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD
Chang H; Li J; Luo Y; Wu B; Yuan C; Geng X
J Gastroenterol Hepatol; 2021 Oct; 36(10):2978-2988. PubMed ID: 33982328
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia disrupts the expression levels of circadian rhythm genes in hepatocellular carcinoma.
Yu C; Yang SL; Fang X; Jiang JX; Sun CY; Huang T
Mol Med Rep; 2015 May; 11(5):4002-8. PubMed ID: 25591621
[TBL] [Abstract][Full Text] [Related]
8. Small heterodimer partner/neuronal PAS domain protein 2 axis regulates the oscillation of liver lipid metabolism.
Lee SM; Zhang Y; Tsuchiya H; Smalling R; Jetten AM; Wang L
Hepatology; 2015 Feb; 61(2):497-505. PubMed ID: 25212631
[TBL] [Abstract][Full Text] [Related]
9. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
[TBL] [Abstract][Full Text] [Related]
10. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
[TBL] [Abstract][Full Text] [Related]
11. miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.
Jia YY; Zhao JY; Li BL; Gao K; Song Y; Liu MY; Yang XJ; Xue Y; Wen AD; Shi L
Oncotarget; 2016 Jun; 7(23):35257-69. PubMed ID: 27153552
[TBL] [Abstract][Full Text] [Related]
12. Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis.
Yi CH; Zheng T; Leaderer D; Hoffman A; Zhu Y
Cancer Lett; 2009 Nov; 284(2):149-56. PubMed ID: 19457610
[TBL] [Abstract][Full Text] [Related]
13. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
[TBL] [Abstract][Full Text] [Related]
14. NPAS2, transcriptionally activated by ARRB1, promotes the malignant behaviours of lung adenocarcinoma cells and regulates the reprogramming of glucose metabolism.
Wang S; Huang C; Zheng Y; Wu X; Zhong Y
Clin Exp Pharmacol Physiol; 2024 May; 51(5):e13860. PubMed ID: 38584327
[TBL] [Abstract][Full Text] [Related]
15. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
[TBL] [Abstract][Full Text] [Related]
16. Nuclear receptor-mediated cell-autonomous oscillatory expression of the circadian transcription factor, neuronal PAS domain protein 2 (NPAS2).
Matsumura R; Matsubara C; Node K; Takumi T; Akashi M
J Biol Chem; 2013 Dec; 288(51):36548-53. PubMed ID: 24196956
[TBL] [Abstract][Full Text] [Related]
17. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
18. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.
Yi C; Mu L; de la Longrais IA; Sochirca O; Arisio R; Yu H; Hoffman AE; Zhu Y; Katsaro D
Breast Cancer Res Treat; 2010 Apr; 120(3):663-9. PubMed ID: 19649706
[TBL] [Abstract][Full Text] [Related]
19. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.
Zhou X; Chen J; Yi G; Deng M; Liu H; Liang M; Shi B; Fu X; Chen Y; Chen L; He Z; Wang J; Liu J
Oncotarget; 2016 Jan; 7(1):873-84. PubMed ID: 26621849
[TBL] [Abstract][Full Text] [Related]
20. Direct regulation of diurnal Drd3 expression and cocaine reward by NPAS2.
Ozburn AR; Falcon E; Twaddle A; Nugent AL; Gillman AG; Spencer SM; Arey RN; Mukherjee S; Lyons-Weiler J; Self DW; McClung CA
Biol Psychiatry; 2015 Mar; 77(5):425-433. PubMed ID: 25444159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]